Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus
about
Midostaurin: an emerging treatment for acute myeloid leukemia patientsUse of natural products as chemical library for drug discovery and network pharmacologyA Pan-GTPase Inhibitor as a Molecular ProbeTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthVatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)Diabetic retinopathy and VEGF.Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteersInvestigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers.Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies.Midostaurin for the treatment of acute myeloid leukemia.Antileukemic effects of midostaurin in acute myeloid leukemia - the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.
P2860
Q26749271-797E3874-BE96-4A1E-B084-06F9D1FE5191Q28487019-8D574C09-3BE3-4AF3-8DAB-BA9EFFD3AF19Q28547072-4929100D-D3CF-4552-A7F5-3F6D04A362D7Q28828739-08BBF0CC-F786-4CF9-976D-CED60BBAB177Q34570873-E9922201-DF58-418C-B590-72A87CB4551AQ34607862-5F2360E7-690C-481E-A016-1675A00B32C9Q35914782-1FE9F89A-538E-4E68-AE9A-B9480BB6BBB1Q37325725-366B67CD-7C0E-4CF2-9EFA-CBFFBA681544Q37992101-87607537-6FFB-469C-BB25-0D162D7564EEQ38671401-F9AE3994-269D-4A65-B622-1D762453CDBBQ39045977-5CA574E0-38A1-49FF-A036-8C43276917B2Q47930594-9143F144-E8DD-441D-B8BE-05753BE6F2E1Q54117167-1DA0A611-84B8-4516-A06E-65518B072274
P2860
Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@ast
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@en
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@nl
type
label
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@ast
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@en
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@nl
prefLabel
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@ast
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@en
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@nl
P2093
P2860
P3181
P356
P1476
Dose- and time-dependent pharm ...... atients with diabetes mellitus
@en
P2093
Horst Schran
James C Kisicki
Ophelia Q P Yin
Peter Graf
Yanfeng Wang
P2860
P304
P3181
P356
10.1177/0091270008318006
P407
P577
2008-06-01T00:00:00Z